San Francisco, CA, United States of America

David Pot


Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Pot

Introduction

David Pot is a prominent inventor based in San Francisco, CA, known for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, Pot has made remarkable advancements in understanding human genes and gene expression products. His work has paved the way for new diagnostic and therapeutic agents that utilize novel human polynucleotides.

Latest Patents

Among his latest patents, "Human genes and gene expression products V" stands out. This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants, and the genes corresponding to these polynucleotides. It also encompasses proteins expressed by these genes, along with diagnostic and therapeutic agents that employ these novel human polynucleotides, including probes, antisense constructs, and antibodies. Another significant patent is "Human genes and gene expression products II," which shares similar themes and innovations, further emphasizing Pot's focus on genetic research and its applications.

Career Highlights

David Pot has had a distinguished career, working with notable companies such as Chiron Corporation and Nuvelo, Inc. His experience in these organizations has contributed to his expertise in biotechnology and innovation.

Collaborations

Throughout his career, Pot has collaborated with esteemed colleagues, including Lewis T Williams and Christoph Reinhard. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

David Pot's innovative work in biotechnology, particularly in human genes and gene expression, has made a significant impact on the industry. His patents and collaborations reflect his dedication to advancing scientific knowledge and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…